Pharmaceuticals

FDA approves Medtronic’s Simplera continuous glucose monitor; Abbott announces collaboration

bexib
By bexib 0 Min Read

Partnership with Abbott on Simplera CGM expands access to advanced automated insulin dosing.

You Might Also Like

SOTIO Biotech Signs Research and License Agreement with Biocytogen for Development of Next-Generation Antibody-Drug Conjugates

Degron Therapeutics and Takeda Enter into Exclusive License and Collaboration Agreement to Develop Molecular Disintegrators for Multiple Indications

US Pharma and Biotech Summit 2024: When FDA needs to regulate AI

10-minute brain scan could improve diagnosis of childhood brain tumors

PharmExec Exclusive: Mark Cuban Talks Drug Prices

Share This Article
Previous Article Bitcoin: Holdings exceed 0.1 BTC as price falls, approaching all-time high
Next Article Investigation finds problems with enforcement of Buy America rules in controversial SEPTA contract
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Fifth Third expands branch network and doubles technology capabilities
Banking
KeyBank increases technology spending by 10% in 2025
Banking
Trump’s fintech appointees could influence regulation
Banking
10 books for better communication
Retail & E-commerce